Zhang Yu, Su Bin, Li Hanping, Han Jingwan, Zhang Tong, Li Tianyi, Wu Hao, Wang Xiaolin, Li Jingyun, Liu Yongjian, Li Lin
Department of AIDS Research, State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, China.
Center for Infectious Diseases, Beijing Key Laboratory for HIV/AIDS Research, Beijing Youan Hospital, Capital Medical University, Beijing, China.
Front Microbiol. 2020 Jan 24;11:21. doi: 10.3389/fmicb.2020.00021. eCollection 2020.
HIV-1 dual infection occurs when an individual is simultaneously or sequentially infected with two or more genetically distinct HIV-1 strains. According to the number of infected strains, HIV-1 dual infection can be divided in double infection and triple infection and so on. Currently, the majority of dual infection cases have been reported to be double infections which can result in detrimental clinical outcomes. The high incidence of double infection among specific high-risk populations increases the likelihood of triple infection, which has been sporadically described. There is no doubt that we are concerned about the association between triple infection and disease progression. However, this relationship is still unclear on the population level. In this study, 70 individuals from the Beijing PRIMO cohort were longitudinally followed up with a median time of 15.75 months for the purpose of investigating the incidence of dual infection. Phylogenetic analyses using bulk and single-genome sequences showed that nine individuals acquired double infection, with the incidence of 9.21 per 100 person-years, and three individuals with triple infection were identified, with the incidence of 3.07 per 100 person-years. The further survival analysis demonstrated that the triple infection group exhibited faster CD4 T-cell decline. In summary, these results demonstrate for the first time that the triple HIV-1 infection might reduce CD4 T-cell counts, which would predict a more rapid disease progression.
当个体同时或先后感染两种或更多基因不同的HIV-1毒株时,就会发生HIV-1双重感染。根据感染毒株的数量,HIV-1双重感染可分为双重感染、三重感染等。目前,大多数双重感染病例报告为双重感染,这可能导致不良临床后果。特定高危人群中双重感染的高发生率增加了三重感染的可能性,三重感染已有零星描述。毫无疑问,我们关注三重感染与疾病进展之间的关联。然而,在人群水平上,这种关系仍不清楚。在本研究中,对来自北京PRIMO队列的70名个体进行了纵向随访,中位时间为15.75个月,以调查双重感染的发生率。使用混合序列和单基因组序列进行的系统发育分析表明,9名个体发生了双重感染,发病率为每100人年9.21例,鉴定出3名个体发生了三重感染,发病率为每100人年3.07例。进一步的生存分析表明,三重感染组的CD4 T细胞下降更快。总之,这些结果首次证明,HIV-1三重感染可能会降低CD4 T细胞计数,这预示着疾病进展更快。